Cargando…
TGF-β2: A Novel Target of CD44-Promoted Breast Cancer Invasion
We have developed a tetracycline (tet)-off regulated expression of CD44s gene in the breast cancer (BC) cell line MCF-7 (B5 clone) and identified TGF-β2 (Transforming Growth Factor beta-2; 3 fold induction) as a potential CD44-downstream transcriptional target by microarray analysis. To further vali...
Autores principales: | Ouhtit, Allal, Madani, Samineh, Gupta, Ishita, Shanmuganathan, Somya, Abdraboh, Mohamed E., Al-Riyami, Hamad, Al-Farsi, Yahya M, Raj, Madhwa HG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753531/ https://www.ncbi.nlm.nih.gov/pubmed/23983821 http://dx.doi.org/10.7150/jca.6638 |
Ejemplares similares
-
Simultaneous Inhibition of Cell-Cycle, Proliferation, Survival, Metastatic Pathways and Induction of Apoptosis in Breast Cancer Cells by a Phytochemical Super-Cocktail: Genes That Underpin Its Mode of Action
por: Ouhtit, Allal, et al.
Publicado: (2013) -
CD146, a novel target of CD44-signaling, suppresses breast tumor cell invasion
por: Ouhtit, Allal, et al.
Publicado: (2017) -
KYNU, a novel potential target that underpins CD44‐promoted breast tumour cell invasion
por: Al‐Mansoob, Maryam, et al.
Publicado: (2021) -
BRIP1 overexpression is correlated with clinical features and survival outcome of luminal breast cancer subtypes
por: Gupta, Ishita, et al.
Publicado: (2017) -
SOD2, a Potential Transcriptional Target Underpinning CD44-Promoted Breast Cancer Progression
por: Alateyah, Nouralhuda, et al.
Publicado: (2022)